Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene. - Wikidata - awgldk - TriplyDB

Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene.

Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene.

http://www.wikidata.org/entity/Q38928679

about

Applications and toxicity of graphene family nanomaterials and their composites Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications.Oxidative Stress and Mitochondrial Activation as the Main Mechanisms Underlying Graphene Toxicity against Human Cancer Cells Glucose-Reduced Graphene Oxide with Excellent Biocompatibility and Photothermal Efficiency as well as Drug Loading.Opportunities and challenges in combination gene cancer therapy.A dual wavelength-activatable gold nanorod complex for synergistic cancer treatment Anticancer Platelet-Mimicking Nanovehicles.Recent advances of cocktail chemotherapy by combination drug delivery systems.Programmable nanomedicine: synergistic and sequential drug delivery systems.Graphene-based nanomaterials: biological and medical applications and toxicity.Nanotechnology for protein delivery: Overview and perspectives.Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer.Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination.Nanomedicines for renal disease: current status and future applications Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Cancer nanomedicine: progress, challenges and opportunities.Nanoformulations for combination or cascade anticancer therapy.ATP-Responsive Drug Delivery Systems Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.Sequential Delivery of Cyclopeptide RA-V and Doxorubicin for Combination Therapy on Resistant Tumor and In Situ Monitoring of Cytochrome c Release.The potential of multi-compound nanoparticles to bypass drug resistance in cancer.Copper Manganese Sulfide Nanoplates: A New Two-Dimensional Theranostic Nanoplatform for MRI/MSOT Dual-Modal Imaging-Guided Photothermal Therapy in the Second Near-Infrared Window.Glycyrrhetinic Acid Functionalized Graphene Oxide for Mitochondria Targeting and Cancer Treatment In Vivo.Functionalized graphene sheets for intracellular controlled release of therapeutic agents.Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy.Cisplatin-induced self-assembly of graphene oxide sheets into spherical nanoparticles for damaging sub-cellular DNA.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Intracellular Mechanistic Understanding of 2D MoS2 Nanosheets for Anti-Exocytosis Enhanced Synergistic Cancer Therapy.Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer.Integration of DNA and graphene oxide for the construction of various advanced logic circuits.A Versatile and Clearable Nanocarbon Theranostic Based on Carbon Dots and Gadolinium Metallofullerene Nanocrystals.Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.An enzyme-free and DNA-based Feynman gate for logically reversible operation.Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery Leveraging Physiology for Precision Drug Delivery

P2860

Q26751311-11BCE93B-D9A4-4F09-8388-8DFA3761D838 Q28072306-4DA76D01-9389-4BE3-9D2F-797F997E8F5B Q28083724-86371131-0D43-4C4C-A8CD-393233112E42 Q35994208-673B3BAC-D966-41B8-A895-949BC7FE04F7 Q37118663-1BA75A06-E4BE-40E4-AC85-9AFB5DE7F63E Q37206530-EA0FD3D6-527B-4F73-9881-E14700D3BBA8 Q37206537-97029288-5827-4306-B111-FD1EC5A4C9BB Q37206908-F9880172-92A7-47FC-B0AD-34AB39CD6EB0 Q38336134-FC5503D2-5C31-4DA7-868E-2C42008F757E Q38561249-4325940F-72ED-4DD4-96FE-D7FB0D8A6F25 Q38605185-5C48572D-CB9A-4CB4-B839-DE1D02DE7A2E Q38664820-9EB8C43C-C180-4E97-B8A2-32CC102B5D78 Q38782710-7181D280-E8B2-4EBB-961B-E71220B9C680 Q38794384-44DB4A43-B741-41FD-9566-69B2EDE540D7 Q38802375-B9C4BB25-E313-4548-ADA5-DF476C93BC6C Q38836010-AA785708-FC2B-44A5-AB82-A68F5E87515F Q39005226-62A1A304-217B-4265-A2E7-16F8FD9F42CA Q39380111-5A6744CA-9713-4010-ABB8-B9834A57315C Q41144817-931C8A18-DF84-4B25-9C65-2766D1651697 Q41430285-C2C77C79-F9CA-42D6-9FF9-A24BCB627438 Q42012799-2D04D717-B9FC-4C0B-8EA5-07732BAFD890 Q47108895-68B7DBBC-08C2-4260-9DFB-B143E44D451A Q47114290-0A7669A8-9A2A-47B3-BBA2-5B34637EE274 Q47114781-827492CE-C807-4D75-B4BB-6E0029C741AE Q47687459-85CA6D20-7DA8-410F-AB96-0CE55A43366D Q47816529-F6B7A06F-E4B5-421A-8AD8-BAB889AA3EB3 Q47994420-26B8F657-174C-4EFD-8374-E2A0FE29D4F7 Q48360004-D0630C38-92B3-4D00-A895-F244E070C2D8 Q50070105-5FF27D5A-40C7-42E1-94FA-0FE16D005EEA Q50181712-33CEDC9A-AB9D-4B71-8584-561C5C7151BE Q50852004-E9C76EA9-C837-412D-B7D6-B79E8508B8F0 Q51143124-895B9F41-3AD2-42D1-8575-512B859A588D Q51262828-50F0F4B2-0AE5-4ACE-8B0B-E663138B08DB Q52862020-7E0AAA23-C660-479B-89BD-573FF9A87C2A Q53484487-2D21467A-707D-4978-813B-F3113BEBEE6C Q57377122-7A26D765-D268-44B6-AC23-175B89A96E46 Q57428850-1569FB2A-5A8D-4CE2-8350-E0E6A0FBDE06

P2860

Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene.

http://www.wikidata.org/entity/Q38928679

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Furin-mediated sequential deli ...... ule drug shuttled by graphene.

@en

type

label

Furin-mediated sequential deli ...... ule drug shuttled by graphene.

@en

prefLabel

Furin-mediated sequential deli ...... ule drug shuttled by graphene.

@en

P1433

Q38928679-D4B90D04-A3B9-4BF2-A5BC-EB552533DBF2

P1476

Q38928679-9753347D-9DC3-45C0-83AF-B42C406703B7

P2093

Q38928679-0A21FC88-0B1B-4570-8C75-9CAEF229C161

Q38928679-3D510E32-41BC-4592-86DB-B0F24CA12FB9

Q38928679-44D14B0F-6CC3-424E-BF22-E1A1AA15C553

Q38928679-68FA42FE-1143-4478-9C86-9668CC11DDD7

Q38928679-6D4C5003-9A73-41EB-8372-B8180941C93D

Q38928679-76B4B08B-3209-4789-9763-8BD9E548357E

Q38928679-A0F1F31A-61D5-4602-8FD9-C51F5950544B

P2860

Q38928679-00AAEE57-ABAA-440F-A0D3-283FFC79D4FD

Q38928679-2DAA980E-802B-4EEF-A420-2506DC44F2B7

Q38928679-3A5A72B5-EB43-4F59-8129-10C84ED23B59

Q38928679-429D2E21-72DA-4A49-B476-201F29211341

Q38928679-45AA8697-5E48-4BB1-8E61-30A6AD008BF6

Q38928679-460EE05A-D006-46AE-846A-86D2186BF40C

Q38928679-4954217A-4E53-4874-A8A1-92A88FCC29FF

Q38928679-4954303F-8C04-425E-99F0-7A3632D1A15F

Q38928679-4B65CF2A-7A38-4859-B1D6-CE9E3378FDA3

Q38928679-5382E3C1-76D9-422F-92A3-782822E8A28E

P304

Q38928679-AD22F3AD-8002-4761-A849-2B77DC994046

P31

Q38928679-0C417F06-5823-48BC-A178-2B6E104A7594

P356

Q38928679-DF9F5488-DC1E-434D-99FE-A6B645744641

P407

Q38928679-0BDD49E0-B8A7-44A6-8524-8600D5AE4B7E

P433

Q38928679-F3FBE274-1569-48FF-A57B-855B79F7A626

P478

Q38928679-EC6BB097-03CA-4034-A04C-783356B45A5F

P577

Q38928679-F4B5178F-2005-4FD0-B29D-BCBEEF1B6D08

P5875

Q38928679-AAB09A66-FA83-4F12-B590-067F7DFEB804

P698

Q38928679-099CD6D0-FDBD-4A52-A178-0E728FD29F63

P921

Q38928679-C1F4FC4B-8E02-4F84-A632-0FA01096C4D2

P932

Q38928679-4E0A7A08-C587-4AA2-ACA3-FBF7F6C85977

P356

P1433

Advanced Materials

P1476

Furin-mediated sequential deli ...... ule drug shuttled by graphene.

@en

P2093

Nancy A Burns

http://www.w3.org/2001/XMLSchema#string

Qiuwen Zhu

http://www.w3.org/2001/XMLSchema#string

Ran Mo

http://www.w3.org/2001/XMLSchema#string

Saad A Khan

http://www.w3.org/2001/XMLSchema#string

Tianyue Jiang

http://www.w3.org/2001/XMLSchema#string

Wujin Sun

http://www.w3.org/2001/XMLSchema#string

Zhen Gu

http://www.w3.org/2001/XMLSchema#string

P2860

The receptor for the cytotoxic ligand TRAIL

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface

Furin at the cutting edge: from protein traffic to embryogenesis and disease

Enzyme-responsive nanomaterials for controlled drug delivery

A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells

Caspases 3 and 7: key mediators of mitochondrial events of apoptosis

Nanocarriers as an emerging platform for cancer therapy

Controlled intracellular self-assembly of gadolinium nanoparticles as smart molecular MR contrast agents

Nano-Graphene Oxide for Cellular Imaging and Drug Delivery.

P304

1021-1028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADMA.201404498

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269578537

http://www.w3.org/2001/XMLSchema#string

P698

25504623

http://www.w3.org/2001/XMLSchema#string

P921

P932

5769919

http://www.w3.org/2001/XMLSchema#string